Why Immune Pharmaceuticals Shares Are Skyrocketing
Shares of Immune Pharmaceuticals saw an incredible gain in Thursday’s session following the announcement of an exclusive license agreement.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 171
Edge Therapeutics Rises Following Registered Direct Offering Announcement
Shares of Edge Therapeutics posted a solid gain in Wednesday’s trading session after the company announced that it would be conducting a registered direct offering of its common stock.
Audentes Therapeutics Gears Up for Secondary Offering
Audentes Therapeutics saw its shares drop early on Wednesday after the company announced the pricing of its secondary offering.
Why One Analyst Is Growing Very Bullish on Life Sciences
Over the past five, 10 and 20 years, the life science and bioproduction segments have tended to outperform the S&P 500 more often than not.
Arena Pharmaceuticals Sinks After Announcing Secondary Offering
Arena Pharmaceuticals saw its shares drop sharply on Tuesday after the company announced a secondary offering of 60 million shares of its common stock.
Why Johnson & Johnson Raised Guidance After Missing Sales Estimates
Health care giant Johnson & Johnson missed sales estimates but beat analysts' profit target. The $30 billion acquisition of Actelion has been included in revised guidance for the 2017 fiscal year.
How Dumping ACA Exchanges Boosted UnitedHealth’s Profits
Exiting the ACA individual exchanges boosted UnitedHealth's profit while nipping its revenues and subscriber numbers. The company also raised its outlook for full-year revenues and profits.
Why HCA Holdings Stock Tumbled Monday
Hospital services provider HCA announced disappointing preliminary financial results for the first quarter of 2017. Shares tumbled more than 3% at the opening bell.
FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte
When drugs are expected to get FDA approval and show positive data but don't, the underlying stocks of drug and biotech companies can see harsh punishment.
Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017
With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and receiving dependable dividends. One place that looks very good now is pharmaceuticals.
Sorrento Therapeutics Gears Up for Secondary Offering
Sorrento Therapeutics saw its shares plunge on Thursday after the company announced a secondary offering.
Neurocrine Biosciences Wins Big With FDA Approval
Neurocrine Biosciences saw its shares jump after the company reported that the FDA had approved Ingrezza capsules for the treatment of adults with tardive dyskinesia.
Short Sellers Back Off Major Biotechs
The March 31 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
Short Sellers Run for Cover From Major Pharma Stocks
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
Analysts Keep Stacking Up Higher Targets and Expectations for Eli Lilly
Several analysts and market pundits have been positive toward Eli Lilly lately, including now a price target raise at JPMorgan.